Linking clinical data and functional analysis of B-cells, Desjardins et al. reported that CVID patients not responding to in vitro stimulation with IL-4 and IL-21 expressed a significantly higher frequency of non-infectious complications [32]. The gene discussed is IL21; the disease is common variable immunodeficiency.